• By Beth Allan, Deanna Kamienski, and Maureen Riordan
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in May 2017.
Infectious disease-focused Accelerate Diagnostics Inc. netted $74.6mm through the upsized follow-on offering of 2.75mm common shares priced at $28.85. The company originally planned to sell 2.5mm shares. (May) Investment Banks/Advisors: BTIG LLC; JP Morgan & Co.; Piper Jaffray & Co.; William Blair & Co.
Aytu BioScience Inc. acquired private women's sexual health company Nuelle Inc. (consumer device to stimulate female sexual arousal)...
